Page last updated: 2024-08-26

fulvestrant and transferrin

fulvestrant has been researched along with transferrin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aleskandarany, M; Ball, G; Douglas Macmillan, R; Ellis, IO; Gee, JM; Green, AR; Habashy, HO; Nicholson, RI; Paish, EC; Powe, DG; Rakha, EA; Staka, CM	1
Donders, EN; Ganesh, AN; Lak, P; Shoichet, BK; Shoichet, MS; Torosyan, H	1

Other Studies

2 other study(ies) available for fulvestrant and transferrin

Article	Year
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast cancer research and treatment, 2010, Volume: 119, Issue:2 Topics: Adult; Antigens, CD; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Chromones; Drug Resistance, Neoplasm; Estradiol; Female; Flavonoids; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Mitogen-Activated Protein Kinases; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Protein Kinase Inhibitors; Receptors, Estrogen; Receptors, Transferrin; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; RNA, Messenger; Tamoxifen; Time Factors; Tissue Array Analysis; Transferrin; Treatment Outcome	2010
Triggered Release Enhances the Cytotoxicity of Stable Colloidal Drug Aggregates. ACS chemical biology, 2019, 07-19, Volume: 14, Issue:7 Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Survival; Colloids; Delayed-Action Preparations; Drug Liberation; Endosomes; Fulvestrant; Humans; Neoplasms; Transferrin	2019

Article

Year

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.

Breast cancer research and treatment, 2010, Volume: 119, Issue:2

Topics: Adult; Antigens, CD; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Chromones; Drug Resistance, Neoplasm; Estradiol; Female; Flavonoids; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Mitogen-Activated Protein Kinases; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Protein Kinase Inhibitors; Receptors, Estrogen; Receptors, Transferrin; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; RNA, Messenger; Tamoxifen; Time Factors; Tissue Array Analysis; Transferrin; Treatment Outcome

2010

Triggered Release Enhances the Cytotoxicity of Stable Colloidal Drug Aggregates.

ACS chemical biology, 2019, 07-19, Volume: 14, Issue:7

Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Survival; Colloids; Delayed-Action Preparations; Drug Liberation; Endosomes; Fulvestrant; Humans; Neoplasms; Transferrin

2019